CREATE Medicines
PrivateLast Round
Series B
May 14, 2026
Total Funding Raised
$245M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
CREATE Medicines is a clinical-stage biotechnology company that pioneers in vivo multi-immune programming to deliver scalable, repeat-dose, off-the-shelf immunotherapies for cancer, autoimmunity, and fibrosis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
CREATE Medicines Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
CREATE Medicines Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | May 14, 2026 | ||||
| Series A Extension | May 18, 2023 | ||||
| Series A | Jan 6, 2021 |
CREATE Medicines Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Newpath Partners | Series A Extension, Series A, Series B |
| ARCH Venture Partners | Series A Extension, Series B |
| Hatteras Venture Partners | Series A, Series A Extension, Series B |
| Alexandria Venture Investments | Series A, Series A Extension, Series B |
| 8VC | Series A, Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 14, 2026
$122M round led by ARCH Venture Partners, Hatteras Venture Partners, and Newpath Partners.
- May 18, 2023
$73M round led by Hatteras Venture Partners.
CREATE Medicines Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about CREATE Medicines's valuation, stock price, and market status.